2017 USCLC Annual Workshop - March 2, 2017 - Orlando, FL
The Workshop is an interactive meeting of dermatologists, medical oncologists, radiation oncologists, pathologists, and transplantation specialists.
Assess the best evidence for therapies to manage advanced stage mycosis fungoides/Sezary syndrome
Debate when to consider using chemotherapy vs. immuntherapies to manage advanced stage mycosis fungoides/Sezary syndrome
Evaluate when to consider stem cell transplant to manage advanced stage mycosis fungoides/Sezary syndrome
Construct a consensus algorithm to manage advanced stage mycosis fungoides/Sezary syndrome
For more information on the conference: www.ascp.org/content/2016
For more information about ASCP: www.ascp.org
Founded in 1987, EADV is a non-profit association whose mission is to advance excellence in clinical care, research, education and training in the field of dermatology and venereology and to act as the advocate and educator of patients particularly those with cutaneous or venereal diseases. The Congress offers to all a collegial, collaborative and congenial setting in which experts, participants and speakers alike can share their knowledge and learn from one another.
For more information: eadvvienna2016.org
The 3rd World Congress of Cutaneous Lymphomas (3WCCL) will be held on October 26-28, 2016 at Columbia University in New York City under the auspice of the International Society of Cutaneous Lymphoma (ISCL), in collaboration with the United States Cutaneous Lymphoma Consortium (USCLC) and the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Task Force (EORTC-CLTF), and organized by the Department of Dermatology at Columbia University. The aim of the conference is to review the current state and to pave the road to the new developments in the basic, translational and clinical research in cutaneous lymphomas and other lymphoproliferative disorders.
For more information: https://register.columbiacme.org/conference.cgi?rm=view&conference_id=734345
The American Society of Hematology (ASH) invites you to save the date for the 58th ASH Annual Meeting in San Diego, California. As the premier hematology event, this meeting will provide attendees with an invaluable educational experience and the opportunity to:
For more information: www.hematology.org/Annual-Meeting/
The 9th Annual T-cell Lymphoma Forum is a 2½-day meeting focusing on the latest information on novel agents and treatment approaches.
The Forum is a comprehensive program intended to inform attendees of the latest research on T-cell lymphoma, including global epidemiology and pathology, immuno-oncology, targeting molecular pathways, new therapeutic approaches, and an update on cutaneous disease. Attendees will have the opportunity to interact with global T-cell lymphoma clinical and industry experts.
This meeting is intended for hematologists, oncologists, and other clinicians and scientists with an interest in T-cell lymphoma.
For more information: www.tcellforum.com
This program is designed for Nurse Practitioners, RN, LPN, MA and all nurses who desire continued education on dermatological conditions.
For more information: www.dnanurse.org
The United States Cutaneous Lymphoma Consortium (USCLC) is a multidisciplinary professional organization dedicated to improve the quality of life and prognosis of patients with cutaneous lymphomas through discovery and application of new knowledge. The Consortium's Annual Workshop is an interactive meeting of dermatologists, medical oncologists, radiation oncologists, pathologists, and transplantation specialists.
For more information: www.usclc.org
Participate in the world's largest dermatology meeting – the 75th Annual Meeting in Orlando, Florida.
The AAD supports the highest-quality patient care by developing and presenting information that enhances continuing education in dermatology. AAD meetings offer the latest on the diagnosis, prevention, and treatment of dermatologic disease from the foremost experts in the field.
For more information: www.aad.org
Future Meeting Dates:
The 6th Annual World Orphan Drug Congress USA is where industry, government and payers come to develop new strategies and partnerships to advance orphan drug development and patient access.
This is the largest, global event that stakeholders go to annually.
The event is dedicated to fostering partnerships and collaboration. It is about expediting orphan drug development and articulating its value, from discovery to patient access, so that manufacturers are guaranteed full and speedy reimbursement.
For more information: www.terrapinn.com/conference/world-orphan-drug-congress-usa
Hilton Portland & Executive Tower
For more information: www.cutaneouslymphoma.org
The Society for Investigative Dermatology (SID) is pleased to present the 2017 Annual Meeting. Meeting attendees will have multiple opportunities to interact with thought leaders in cutaneous biology from around the globe. The SID community includes representation from a broad range of specialties and disciplines.
For more information: www.sidnet.org
The Association of Oncology Social Work (AOSW) is a nonprofit, international organization dedicated to the enhancement of psychosocial services to people with cancer and their families. Created in 1984 by social workers interested in oncology and by existing national cancer organizations, AOSW is an expanding force of psychosocial oncology professionals.
Future Meeting Dates:
To learn more: www.aosw.org
The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties, making it an excellent venue for exploring the theme of the Meeting — "Science and Society." Attendees of the 2015 Annual Meeting will find cutting-edge scientific presentations and comprehensive educational content.
For more information: am.asco.org
Future Meeting Dates:
June 1-5, 2018
May 31-June 4, 2019
May 29-June 2, 2020
The CDA Annual Conference is committed to presenting quality and relevant academic programming and continues to be the key gathering of the year for dermatologists from across Canada. From panel discussions to poster sessions, we’re looking forward to sharing diverse ideas and sparking dynamic dialogue. The peer-reviewed paper sessions will help sharpen our combined knowledge of the art and science of dermatology.
For more information: www.dermatology.ca
The European Organisation for Research and Treatment of Cancer (EORTC) is an independent research organization dedicated to investigator driven clinical trials and translational research. The date of it's Cutaneous Lymphoma Task Force (CLTF) will be meeting will be announced.The field of Cutaneous lymphomas is changing rapidly with the development of new original and more targeted treatments.The different subtypes of cutaneous lymphomas and their pathophysiology is also subject of numerous research projects. This meeting will review the latest advances relating to cutaneous lymphomas and the clinical practice including new treatments and trials.
For more information: www.eortc.org/research-groups/cutaneous-lymphoma-task-force
The International Society for the Study of Itch (IFSI) is a multidisciplinary international association of clinical practitioners, researchers and scientists dedicated to improving our understanding and treatment of pruritus for the benefit of suffering patients worldwide. The Society is a non-profit professional organization (registered in NC, USA). Membership is open to clinicians, researchers, scientists and other health professionals engaged in the research and treatment of itch.
The IFSI conducts international meetings every second year (World Congress of Itch, WCI) where researchers present the latest findings in the field.
More information to come.
The World Congress of Dermatology is the world’s oldest and continuous international dermatology meeting. The first Congress in 1889 pre-dated the modern Olympics by seven years. The last Congress to be held in North America was in New York in 1992.
For more information: www.wcd2019milan.org
This is an automatic translation service and therefore the
Cutaneous Lymphoma Foundation is not responsible
for any potential translation inaccuracies.